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 I 
The thesis entitled “Total Synthesis of Natural Products Containing δ-Lactone 
Moiety” is divided into four chapters. 
CHAPTER I: This chapter is divided into two sections.  
Section A: This section deals with the introduction, earlier synthetic approaches of 
Pectinatone, Siphonarienal and Siphonarienone. 
Section B: This section describes the stereoselective total synthesis of Pectinatone,  
Siphonarienal and Siphonarienone. 
CHAPTER II: This chapter deals with the introduction, earlier synthetic approaches 
and the stereoselective total synthesis of (3R,4S,5S,9S)-3,5,9-trihydroxy-4-
methylundecanoic acid δ-lactone.  
CHAPTER III: This chapter describes the introduction, earlier synthetic approaches 
and the stereoselective total synthesis of (6R)-6-[(4R,6R)-4,6-dihydroxy-
10-phenyldec-1-enyl]-5,6-dihydro-2H-pyran-2-one.  
CHAPTER IV:  This chapter is divided into two sections. 
Section A: Introduction & Synthesis of (R)- and (S)-Massoialactones. 
Section B: Stereoselective formal Synthesis of Natural 1,3-Polyol/α-Pyrone 
Enantiomers. 
Chapter I, Section A:  
Section A describes the biological activities of structurally unique natural 
products that are mainly accumulated in marine living organisms. Several of these 
compounds shown pharmacological activities and are helpful for the invention and 
discovery of bioactive compounds, primarily for deadly diseases like cancer, acquired 
Immuno - Deficiency Syndrome (AIDS), arthritis etc. While other compounds have 
been developed as analgesics or to treat inflammation etc. The life-saving drugs are 
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 II 
mainly found abundantly in marine microorganisms, algae and invertebrates, while they 
are scarce in vertebrates. Modern technologies have opened vast areas of research for 
the extraction of biomedical compounds from marine organisms. 
Previous synthetic approaches of Pectinatone, Siphonarienal and Siphonarienone have 
been also discussed.  
 
Chapter I, Section B:    
This section describes the stereoselective total synthesis of Pectinatone, 
Siphonarienal and Siphonarienone.  
Marine mollusks of the genus Siphonaria is the rich source of polypropionates, 
polyether antibiotics
 
and macrolides. In 1983 Biskupiak and Ireland first reported the 
isolation of (+)-pectinatone from the skin extract of the pulmonate Siphonaria pectinata 
collected on the sea wall at the entrance of Key Biscayne (Florida), displayed antibiotic 
properties against Gram-positive bacteria such as Staphylococcus aureus and Bacillus 
subtilis, as well as yeasts Candida albicans and Saccharomyces cerevisiae. (+)-
Pectinatone is a tetrasubstituted δ-lactone with a polypropionate side chain. The 
originally proposed configuration of (+)-pectinatone was later revised by Garson in 
1990 as shown in the Figure 1.  
Siphonarienal and Siphonarienone are isolated from Siphonariea grisea. Due to 
their biological activity combined with unique and challenging structure have made 
these compounds exciting targets for total synthesis (Figure 1).   
 
 
 
 
 
  
 
 As part of our study towards the synthesis of (+)-Pectinatone 1, Siphonarienal 2 
and Siphonarienone 3 we adopt a linear strategy, disconnecting the C6-C7 of (+)-
O
OO
OH
H
O
Polypropionates
Figure 1
Siphonarienal 2 Siphonarienone 3(+)-Pectinatone 1
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 III 
Pectinatone as carbon back bone intermediate 5 for the three polypropionates 1, 2 and 3. 
The synthesis of intermediate 5 commenced from lactone 7, which was generated from 
bicyclic ketone 10 (Scheme 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1: Retrosynthetic Analysis 
Synthesis of lactone intermediate 7:   
 The synthesis of lactone intermediate 7 was achieved from bicyclic ketone 10, 
which was inturn synthesized from furan and 2,4-dibromo-3-pentanone 9. Accordingly, 
the acid catalyzed dibromination of 3-pentanone 8 afforded the dibromo compound 9. 
The dibromo compound 9 when treated with furan in the presence of Zn-Cu couple 
underwent a [3+4] cycloaddition reaction to afford compounds 10, 11 and 12 in a ratio 
8:1:1. These bicyclic ketones on selective reduction with DIBAL-H gave 13 as major 
isomer along with other isomers (Scheme 2). 
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The required alcohol 13 was isolated from the other isomers using column 
chromatography and the structure was confirmed from spectral studies. The hydroxy 
group of compound 13 was protected as its p-methoxybenzyl ether 14 using NaH and 
p-methoxybenzyl bromide. Asymmetric hydroboration of olefin 14 using (–)-
diisopinocamphenylborane (Ipc2BH) proceeded smoothly to give 15 with high 
enantiomeric purity. The alcohol 15 was converted to the lactone 7 by a two step 
sequence, PCC oxidation of alcohol 15 followed by Baeyer-Villiger oxidation of keto 
compound 16 to afford the lactone 7 (Scheme 3).  
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 V 
Synthesis of Pectinatone, Siphonarienal and Siphonarienone (polypropionates):  
The synthesis of polypropionates 1, 2 and 3 was started from lactone 7 which is 
having three stereogenic functionalized carbons. The lactone 7 was subjected to 
regioslective allylation using LHMDS and allylbromide to afford the allylated lactone 
17. Reductive opening of bicyclic lactone 17 with LiAlH4 afforded the triol 6, which 
was further treated with 2,2-DMP and CSA (cat.) to give acetonide compound 18. The 
hydroxy group of compound 18 was protected as benzyl ether 19, using NaH and BnBr 
in THF followed by cleavage of the acetonide group using 2N HCl in THF/H2O (1:1) 
afforded diol 20. Selective protection of primary hydroxy group of diol 20 was 
achieved with tosyl chloride and Et3N to give 21. The tosylate 21 on treatment with 
LiAlH4 afforded 22. The secondary hydroxy group of 22 was converted into the 
xanthate ester and reduced to give compound 23.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4 
Oxidative removal of the PMB ether of 23 with DDQ in CH2Cl2-H2O gave 24. 
The compound 24 was converted into the xanthate ester and reduced (same as above 
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discussed) to furnish 26.   Compound 26 was subjected to hydrogenolysis and 
hydrogenation at one pot reaction using Pd/C, H2 followed by oxidation with 
IBX/DMSO afforded aldehyde 5 (Scheme 4).   
The aldehyde 5 was subjected to the corresponding Wittig yilides to give the 
target compounds 2 and 3 (Scheme 5).    
 
 
 
 
 
 
 
 
Scheme 5  
Whereas treatment of ester 27 with N-methoxy, N-methyl ammonium chloride 
and  
i
PrMgCl, in anhydrous THF, at  –20 °C-0 °C afforded Weinreb amide 29a in 71% 
yield. 
The amide 29a was added to the lithium enolate of EtCOCH(CH3)COOEt
 
generated by the addition of LDA at –78 
o
C, resulted the diketo ester 29, which was 
subjected to 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in toluene at reflux temperature 
led to yield 1 (Scheme 6).  
 
 
 
 
 
 
 
 
 
In conclusion, the total synthesis of (+)-Pectinatone, Siphonarienal and 
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consecutive stereogenic centres via desymmetrization from readily available starting 
materials. 
CHAPTER II:  
 This chapter describes the previous synthetic approaches and the stereoselective 
total synthesis of (3R,4S,5S,9S)-3,5,9-trihydroxy-4-methylundecanoic acid δ-lactone. 
 During the studies of the biosynthesis of spinosyns, a family of new insect 
control agents, a truncated version of  the spinosyn polyketide synthase was expressed 
in the heterologous host Saccharopolyspora erythraea JC2.
 
This resulted in the 
formation of a novel pentaketide lactone that was identified as (3R,4S,5S,9S)-3,5,9-
trihydroxy-4-methyl undecanoic acid δ-lactone 30. The discovery of this molecule 
helped in understanding the crucial steps of spinosyn biosynthesis, which supported the 
widely accepted hypothesis of step by step functionalization of the growing polyketide 
chain in the biosynthesis of macrolides.
 
 Synthesis of the target molecule 30 was started from aldehyde 34, which in turn 
prepared from three different routes (Scheme 7). 
 
 
 
 
 
 
 
 
 
 
  
 In route 1, the commercially available 3-butyn-1-ol was used as starting 
material. This was subjected to formylation on acetylenic carbon using EtMgBr and 
formaldehyde. In the next step, partial reduction of triple bond to double bond was 
carried out using LiAlH4 to afford 40. Sharples asymmetric epoxidation, chlorination 
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followed by opening of epoxide using lithium in liquid NH3 and ethylene oxide 
liberated the diol 43 (Scheme 8). 
 
 
 
 
 
 
 
  
Selective protection of primary hydroxy group in diol 43 was successively 
carried out using benzylbromide, sodium hydride in anhydrous DMF to yield 44. 
Protection of secondary hydroxy group as methoxymethyl (MOM) and deprotection of 
THP followed by tosylation, reductive elimination of tosylate and hydrogenation in the 
presence of Pd/C liberates alcohol 47 (Scheme 9).    
 
 
 
 
 
 
 
 
 
 In route 2, 5-hexyn-1-ol was converted to hydroxy epoxide 36 same as above 
discussed in scheme 8, conversion of hydroxy group to iodo group and opening of 
epoxide followed by Pd/C hydrogenation liberates 47 (Scheme 9).  
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In route 3, epoxidation of benzyl ether of 5-hexen-1-ol 55 was carried out using 
m-CPBA to afford epoxide 56. The epoxide 56 was subjected to hydrolytic kinetic 
resolution (HKR)
 
using (R,R) chiral Jacobsen’s catalyst to afford enantioenriched 
(>96% ee) epoxide 37 and terminal diol 57 (Scheme 11). 
 
   
 
 
 
 
 
 
 
 
Epoxide 37 was then converted to one carbon homologated chiral allylalcohol 
52 by using dimethyl sulfonium methylide.
 
Conversion of 52 into 47 was achieved as 
discussed in scheme 10 (Scheme 11).   
The analytical data of 47 prepared by three routes matched with each other. Now 
the compound 47 was subjected to oxidation using IBX/DMSO to afford aldehyde 34, 
which on Evans syn aldol reaction using the enolate of chiral N-propionyloxazolidinone 
33 afforded the aldol adduct 31 in higher conversion and diastereoselectivity (78%, de 
98%), after chromatographic purification. Esterification of 32 was successively carried 
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 X 
out using EtMgBr (1M solution in THF) and MeOH-CH2Cl2 (1:1) to afford 58 (Scheme 
12).   
  
 
 
 
 
 
 
 
 Conversion of ester 58 to β-keto ester 31 was successfully carried out at -78 to -
15 
o
C using lithium diisopropylamide and tert-butylacetate in anhydrous THF. 
 
 
 
 
 
 
 
 
 
 Inductive reduction of 31 was carried out using diethylmethoxyborane and 
sodium borohydride in THF-MeOH solution at 78 
o
C to afford 59. The synthesis of 
target molecule 30 was achieved from dihydroxy ester 59 using HCl/H2O in THF at 
room temperature in 75% yield (Scheme 13). 
 
CHAPTER III:  
 This chapter describes the introduction, previous synthetic approaches and the 
stereoselective total synthesis of (6R)-6-[(4R,6R)-4,6-dihydroxy-10-phenyldec-1-enyl]-
5,6-dihydro-2H-pyran-2-one.  
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 α-Pyrone derivatives (5,6-dihydro-2H-pyran-2-ones) isolated from natural 
sources have attracted much attention during the last decade due to their medicinal 
potential as antiviral, antifungal, antibacterial, antimalarial and antitumor properties as 
well as plant growth inhibition. (6R)-6-[(4R,6R)-4,6-Dihydroxy-10-phenyldec-1-enyl]-
5,6-dihydro-2H-pyran-2-one 60 is one such natural product, isolated from Ravensara 
crassifolia by Hostetmann and co-workers. The absolute configuration of these 6-
alkylated α-pyrones from Ravensara crassifolia was determined by LC-NMR.
 
 
 
 
 
 
 
 
 
 
 
 
  
 The synthesis commenced from R-(-)-benzyl glycidyl ether 69 (Scheme 14). 
Jacobson resolution of 68 using (S,S)-(salen)Co(II) precatalyst, AcOH and H2O (0.51 
equiv) for 22 hours resulted in (R)-benzyl glysidyl ether 69. Regioselective opening of 
epoxide 69 with vinylmagnesium bromide (formed by addition of vinyl bromide to Mg 
in THF) in the presence of CuCN gave homoallylic alcohol 66 (Scheme 15). 
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Scheme 14: Retrosynthetic analysis
MOM
O
BnO
OH
BnO
O
BnO
VinylMgBr, CuCN
  -78 oC to -40 oC, 4 h
69
66
92%
68
  (S,S) Co-(salen)
AcOH, H2O, THF
0 oC-rt., 22 h
Scheme 15
                                                                                                                               Synopsis 
 
 XII 
Prins cyclisation in the presence of TFA in CH2Cl2 resulted in trifluoroacetate 
70a. After work up, the crude trifluoroacetate 70a on hydrolysis with K2CO3 in MeOH 
yielded desired trisubstituted pyran 70b (Scheme 16).  
 
 
 
 
 
 
 
 
 
 
The secondary hydroxy group in 70b was protected as its methoxy methyl 
(MOM) ether 71 by treating with 2 equivalents of MOMCl in the presence of 
i
Pr2NEt in 
CH2Cl2. Substrate 71 on treatment with lithium in liquid NH3 underwent debenzylation 
to produce alcohol 72. Replacement of hydroxy group in 72 with iodine was 
successively carried out by using triphenyl phophene, imidazole in diethyl ether and 
acetonitrile solution to afford 73. The compound 73 was treated with unactivated zinc in 
refluxing ethanol to afford 62 (Scheme 17).  
 
 
 
 
 
 
The other olefinic moiety was prepared from homoallylic alcohol 64 same as 
discussed above in scheme 8, but ()-DET was used to prepare asymmetric epoxide 
41a. The epoxide was converted into MOM protected compound 53a same as shown in 
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 XIII 
scheme 10, finally THP group was deprotected using PPTS in methanol at room 
temperature (Scheme 18).   
 
 
   
 
 
 
 
 
Olefin cross-metathesis reaction of compounds 62 and 63 using second 
generation of Grubbs’ catalyst produced 74.  
 
 
 
 
 
 
 
 
 
The newly created two hydroxyl groups of 15 were protected as its MOM ether 
75 in the presence of MOM chloride, DIPEA and DMAP in CH2Cl2 (Scheme 19).   
 Deprotection of THP of 75 carried out by using PPTS in MeOH to afford 61. 
Oxidation of alcohol in 61 with IBX in DMSO and CH2Cl2 solution afforded 76. The 
crude compound 76 was then subjected to Stills modification of Horner Wodsworth-
Emmons reaction using NaH and bis (2,2,2-trifluoromethyl) (methoxy carbonyl 
methyl) phosphonate in anhydrous THF at –78 
o
C to afford (Z)-olefin ester 77 
exclusively 88% yield with the traces of (E)-olefin ester, that could be separated by 
column chromatography. The cyclization of compound 77 was effected in 
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 XIV 
CH3CN:MeOH (1:1) in the presence of catalytic amount of CeCl3.7H2O for 12 h at 
room temperature to afford the target molecule 60 (Scheme 20).    
 
 
 
 
 
 
 
 
 
Chapter IV: This chapter is divided into two sections. 
Section A: This section describes the introduction, earlier synthetic approaches 
and the stereoselective total synthesis of (R)- and (S)-Massoialactones. 
The 6-substituted chiral δ-lactone moiety is present in a number of natural 
products and exhibit significant bioactivities. Massoialactone 78 belongs to this family, 
first isolated from the bark oil of Cryptocarya massoia by Abe in 1937. Later this 
lactone has also been isolated as a flavour substance from cane molasses and jasmine 
flowers. The R enantiomer has been identified as the defense secretion of two species of 
formicin ants of the genus Camponotus.  
 
 
 
 
 
 
 The synthesis of (R)- and (S)-Massoialactones commenced from commercially 
available (S)-butane-1,2,4-triol 80.  
 The known (S)-epoxide 85 could be derived from (S)-butane-1,2,4-triol 80.  
Selective opening of epoxide 85 with CuI and n-BuLi
 
furnished 86. The secondary 
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 XV 
hydroxyl group in compound 86 was protected as TBS ether 87 using TBSCl, 
imidazole in CH2Cl2.  Oxidative deprotection of the PMB group using DDQ in aq 
CH2Cl2 gave the primary alcohol 88, which on oxidation with IBX in DMSO furnished 
the corresponding aldehyde 89. A modified Still’s Horner Wadsworth-Emmons 
reaction of 89 using methyl(bistrifluoroethyl) phosphonoacetate in the presence of NaH 
in THF gave Z-unsaturated ester 90, exclusively. Subsequent cyclization of Z-ester 
using a catalytic amount of p-TsOH in methanol and benzene furnished the target 
molecule, 78 by in situ deprotection of TBDMS group (Scheme 22).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preparation of R-epoxide 92 from PMB protected S-butane triol 83 was 
successively carried out by protecting primary hydroxy group as TBS using TBSCl and 
imidazole in anhydrous CH2Cl2.  
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 Tosylation of secondary hydroxy group using TsCl in anhydrous CH2Cl2 and 
DMAP as catalyst afforded 91, which on treatment with tetrabutyl ammonium fluoride 
in THF underwent deprotection of TBS and formation of epoxide 92 at one pot 
synthesis. The epoxide 92 was converted to lactone 79 same as discussed in scheme 20 
(Scheme 23).  
Section B: This section describes the introduction, earlier synthetic approaches 
and the stereoselective formal synthesis of natural 1,3-Polyol/α-Pyrone enantiomers.  
The 1,3-polyol/pyrones 93 and 94 have been isolated from Ravensara anisata 
and possess inhibitory activity against C. Cucumerinum. 
 
 
 
 
 
 
 
Scheme 24: Retrosynthetic analysis 
 Preparation of epoxide 92 was already described in section A, chapter IV. The 
epoxide opening with the Grignard reagent prepared from (3-bromopropyl) benzene and 
Mg in the presence of CuI in THF at 0 
o
C for 2 h afforded the secondary alcohol, wihich 
was protected as (tert-Bu)Me2Si (TBS) ether to give compound 98. Debenzylation of 98 
was achieved using Li in liquid NH3 to afford a primary alcohol 100, which was 
oxidized to the aldehyde 101 using 2-(iodooxy)benzoic acid (IBX). Aldehyde 101 gave 
hydroxy protected β-ketoester 97 on treatment with ethyl diazoacetate in the presence of 
SnCl2 in anhydrous CH2Cl2 (Scheme 25).  
OPMB
O
91
7983
OPMB
OTs
TBSO
see scheme 22
Scheme 23
(a) TBSCl, imidazole,
CH2Cl2, 0 
oC, 2 h, 90%
(b) TsCl, DMAP,
CH2Cl2, rt, 24 h, 90%
Bu4NF, 
anhydrous THF,
rt, 96%.
92
OTBS
OBn
9298
( )3
O O O
O
R1 R2
93 R1 = Ac, R2 = H
94 R1 = H, R2 = Ac
95 R1 = Ac, R2 = Ac
96
O
OBn
97
( )3
O O OH
( )3
O O O
OEt
( )3
TBS
99
OH
O
O
OMe
MeO
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 Removal of the TBS group using Bu4NF (TBAF) in THF yielded δ-hydroxy β-
ketoester 102, and enantioselective reduction
 
of the keto group with catecholborane 
furnished 1,3-syn diol 103. Acetonide protection of the diol followed by DIBAL-H 
reduction gave aldehyde 105. We envisioned that a chiral asymmetric allylation of 
aldehyde 105 could be achieved using allyltributyl stannane and a chiral Lewis acid. 
Thus treatment of aldehyde 105 with allyl(tributyl)stannane and (R)-BINOL afforded 
the chiral homoallyl alcohol 96 in good yield with high enantioselectivity. Next, 
acrylation of secondary hydroxy group in 96 was carried out efficiently with acryloyl 
chloride in the presence of Et3N to yield a diene 106, a precursor for ring-closing 
metathesis. The diene was reacted with the 10 mol-% of Grubbs’ catalyst 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
OBn
BrPh
OBn
OTBS
OH
OTBS
O
OTBS
O O
OEt
O
O O O
OEt
OH O
OEt
O OH O
OEt
OH
O OO
H
O OHO O OO
O
O OO
O
OH OOH
O
92
Mg, CuI, anhy. THF
98
( )3
(b) TBSCl/Imidazole
anhy. CH2Cl2
100
( )3
101
( )3
Li, liq. NH3, 
10 min, 92%
anhy. CH2Cl2,  
102
97
103
104 105
Ethyl diazoacetate, 
 30 min, 83%
anhy. THF/Bu4NF,
0.5 h, 85%
Catecholborane, 
anhy. THF, 5 h, 70%
2,2-DMP, anhy. CH2Cl2,
PPTS, 12 h, 90%
DIBAL-H, 
 -78 oC, 70%
( )3
( )3 ( )3
( )3 ( )3
anhy. CH2Cl2, SnCl2, 
107 108
96
( )3
106
( )3
( )3 ( )3
(R)-(+)-1,1´-Binaphthalene-
2,2´-diol, (iPrO)4Ti, 
 0 oC -rt., anhy. CH2Cl2, 3 h
Acryloyl chloride, 
EtN(iPr)2, 
 0 oC-rt, 3 h, 89%
Grubbs' generation I,
anhy. CH2Cl2, 0 
oC
-r.t.,6 h, 95%
PPTS, MeOH,
rt, 4 h, 81%
93, 94 and 95
IBX, DMSO, 
(a)
Scheme 25
anhy. THF,  -33 oC, 
anhy. CH2Cl2,
anhy. CH2Cl2,
allyl tributyl tin
TBS
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 XVIII 
[bis(tricyclohexylphosphine)benzylidene ruthenium(IV) dichloride] in CH2Cl2 under N2 
atmosphere to furnish lactone 107, which on cleavage of the acetonide with pyridinium 
p-toluenesulfonate (PPTS) in MeOH yielded dihydroxylactone 108. Since the 
monoacetylation of lactone 108 to the target molecules 93, 94 and 95 has already been 
reported, the present sequence constitutes a formal synthesis of pyrones 93, 94 and 95 
(Scheme 25). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
